Clinical Trial Update: Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial at Yale University aims to study the genetics of cannabis use disorder and individual cannabinoid response in humans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder
• Schizophrenia

Snippet

Sponsor: Yale University | Conditions: Schizophrenia, Cannabis Use Disorder | Phase 1 | Status: RECRUITING